Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
She joins Enveda from Gilead Sciences
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Subscribe To Our Newsletter & Stay Updated